Company Filing History:
Years Active: 2018
Title: Innovations in Melanoma Diagnosis by Gemma Lancaster
Introduction
Gemma Lancaster is an accomplished inventor based in Lancashire, GB. She has made significant contributions to the field of medical diagnostics, particularly in the detection and prognosis of malignant melanoma. Her innovative approach combines advanced techniques in blood perfusion dynamics with clinical applications.
Latest Patents
Gemma Lancaster holds a patent for a diagnostic method and device aimed at diagnosing malignant melanoma. The invention involves measuring two or more markers in blood perfusion dynamics at and/or around a skin lesion site. It also includes determining if these markers differ from normal values, providing a reliable method for assessing the likelihood of developing this serious condition.
Career Highlights
Lancaster is associated with Lancaster University Business Enterprises Limited, where she applies her expertise in medical research and innovation. Her work has garnered attention for its potential to improve early detection and treatment outcomes for patients at risk of malignant melanoma.
Collaborations
Gemma collaborates with notable colleagues, including Aneta Stefanovska and Marco Rossi. Their combined efforts contribute to advancing research and development in the field of medical diagnostics.
Conclusion
Gemma Lancaster's innovative work in diagnosing malignant melanoma showcases her commitment to improving healthcare outcomes through technology. Her contributions are paving the way for more effective diagnostic methods in the medical field.